Digital Health
Health ecosystems: cooperation between academia, healthcare, and industry
Roundtable with representatives from hospitals, universities, and industry to explore how collaboration among the different actors in the health ecosystem can foster knowledge transfer and generate real societal impact through health innovation.
Industry
Solid-State Strategies for Drug Development and Impact on Commercialization
The solid state of an API is crucial for its development, influencing solubility, stability, bioavailability, and manufacturability. The presentation outlines key principles of solid forms, including polymorphism, salts, and cocrystals, plus their impact on performance. It also reviews regulatory expectations and IP aspects, highlighting how solid form strategy reduces risks and supports long term value.
Industry
Conquer the QMS Mountain
Writing a quality management system without a clear strategy will often lead to a tangled and complicated web of procedures that create a huge administrative burden without offering the needed support for your operations. Join this webinar to get some insights in how the right input and a step-wise approach can lead you on the right path towards a QMS certification.
Innovation
From Pilot to EU Rollout: Making AI Translation Quality Compliance-Ready in HealthTech
Across Life Sciences, MedTech or Digital Health (HealthTech) organizations depend on translated documentation to enter new markets and remain compliant, but unmanaged multilingual requirements increase risk, cost and delay.
This webinar presents a practical, risk-based framework to define fit-for-purpose translation quality, balance AI and human review, and support compliant market expansion.
Research
3D Electron Diffraction for Structure Elucidation: Is It Science Fiction?
3D Electron Diffraction (3D ED) is revolutionizing structure determination from nanocrystals (10–500 nm) using only nanograms of sample. With the first dedicated electron diffractometer in Europe, we can directly analyse complex powders, from pharmaceuticals to pollutants, without crystallization and with fast chirality determination
Innovation
Towards a Personalized Medicine Approach in Psychology
The PERMEPSY project, funded under the European ERA PerMed programme, focuses on developing an AI‑based predictive software platform to personalize psychological treatment for psychosis. This session outlines the project’s main challenges and highlights how clinical, technological, and research partners across Europe collaborate to advance precision mental‑health care through innovati
Innovation
From Research to Care: Rethinking Women’s Health with Innovation and Data
Women’s health remains an ongoing challenge. Gender biases in research, the lack of specific data, and the underrepresentation of women in clinical studies hinder truly equitable care.
This session aims to address the need for an integrated and differential approach to women’s health, one that considers all levels of care—from primary care to hospital care—and incorporates the biological, social, and cultural factors that influence it.
The goal is to foster discussion and share experiences that will help move towards more just, equitable, and women-centered care.
Innovation
Challenges and strategies for intellectual property management in the Pharma sector
A session exploring how companies manage intellectual property across the product lifecycle. Speakers will share strategic and legal perspectives on building competitive portfolios, creating value, diversifying assets, and collaborating with key stakeholders to anticipate challenges such as patent cliffs and evolving market pressures.
Research
British Consulate Brunch – ONCOLOGY Spotlight Talk and Networking
The British Consulate in Barcelona will host a Networking Brunch on Wednesday 18th February from 12:00 – 13:30. It will focus on oncology with a chance to hear from leading British companies with topics e.g. drug discovery, clinical trials, and R&D in the UK. Attendees will enjoy welcome drinks. a spotlight session with British expert speakers and networking lunch with guests working in oncology.
Research
Polysorbates and beyond: Optimising surfactant strategy in biologic drug formulation
Biologic formulations face stability challenges that surfactants help overcome. In this webinar, Croda experts share surfactant selection strategies for biotherapeutics, featuring never-before-seen stability data comparing polysorbates, poloxamers, and innovative alternatives to enhance protein integrity and performance.
